Septerna, Inc. Common Stock SEPN

$47.76 +22.93% at last close
Market Cap$2.23 billion
P/E Ratio
Div Yield
Volume1.16M
52-Week Range $10.62$48.00

Key Stats

Today's Range
$38.62 $48.00
50-Day Range
$27.07 $48.00
52-Week Range
$10.62 $48.00
Volume
1.16 million shs
Average Volume
423K shs
Market Cap
$2.23 billion
P/E Ratio
Dividend Yield

Short Interest

Short Interest
0.97%
Days to Cover
1.19

About Septerna, Inc. Common Stock

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.

Sector
PHARMACEUTICAL PREPARATIONS
Employees
130
Exchange
XNAS
Listed
2024-10-25

Related Stocks

Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.